IBDEI10S ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18177,1,2,0)
 ;;=2^307.50
 ;;^UTILITY(U,$J,358.3,18177,1,5,0)
 ;;=5^Eating Disorder, NOS
 ;;^UTILITY(U,$J,358.3,18177,2)
 ;;=^37864
 ;;^UTILITY(U,$J,358.3,18178,0)
 ;;=333.99^^98^1035^1
 ;;^UTILITY(U,$J,358.3,18178,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18178,1,2,0)
 ;;=2^333.99
 ;;^UTILITY(U,$J,358.3,18178,1,5,0)
 ;;=5^Acute Akathisia
 ;;^UTILITY(U,$J,358.3,18178,2)
 ;;=^303698
 ;;^UTILITY(U,$J,358.3,18179,0)
 ;;=332.0^^98^1035^3
 ;;^UTILITY(U,$J,358.3,18179,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18179,1,2,0)
 ;;=2^332.0
 ;;^UTILITY(U,$J,358.3,18179,1,5,0)
 ;;=5^Parkinsonism
 ;;^UTILITY(U,$J,358.3,18179,2)
 ;;=^304847
 ;;^UTILITY(U,$J,358.3,18180,0)
 ;;=333.79^^98^1035^2
 ;;^UTILITY(U,$J,358.3,18180,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18180,1,2,0)
 ;;=2^333.79
 ;;^UTILITY(U,$J,358.3,18180,1,5,0)
 ;;=5^Acute Dystonia
 ;;^UTILITY(U,$J,358.3,18180,2)
 ;;=^334068
 ;;^UTILITY(U,$J,358.3,18181,0)
 ;;=333.85^^98^1035^4
 ;;^UTILITY(U,$J,358.3,18181,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18181,1,2,0)
 ;;=2^333.85
 ;;^UTILITY(U,$J,358.3,18181,1,5,0)
 ;;=5^Tardive Dyskinesia
 ;;^UTILITY(U,$J,358.3,18181,2)
 ;;=^334069
 ;;^UTILITY(U,$J,358.3,18182,0)
 ;;=V87.39^^98^1036^1
 ;;^UTILITY(U,$J,358.3,18182,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18182,1,2,0)
 ;;=2^V87.39
 ;;^UTILITY(U,$J,358.3,18182,1,5,0)
 ;;=5^Cont/Exp Hazard Sub NEC
 ;;^UTILITY(U,$J,358.3,18182,2)
 ;;=^336815
 ;;^UTILITY(U,$J,358.3,18183,0)
 ;;=310.0^^98^1037^2
 ;;^UTILITY(U,$J,358.3,18183,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18183,1,2,0)
 ;;=2^310.0
 ;;^UTILITY(U,$J,358.3,18183,1,5,0)
 ;;=5^Frontal Lobe Syndrome
 ;;^UTILITY(U,$J,358.3,18183,2)
 ;;=^265201
 ;;^UTILITY(U,$J,358.3,18184,0)
 ;;=310.1^^98^1037^3
 ;;^UTILITY(U,$J,358.3,18184,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18184,1,2,0)
 ;;=2^310.1
 ;;^UTILITY(U,$J,358.3,18184,1,5,0)
 ;;=5^Personality Chg d/t TBI/Lesion
 ;;^UTILITY(U,$J,358.3,18184,2)
 ;;=^331953
 ;;^UTILITY(U,$J,358.3,18185,0)
 ;;=310.2^^98^1037^4
 ;;^UTILITY(U,$J,358.3,18185,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18185,1,2,0)
 ;;=2^310.2
 ;;^UTILITY(U,$J,358.3,18185,1,5,0)
 ;;=5^Postconcussion Syndrome
 ;;^UTILITY(U,$J,358.3,18185,2)
 ;;=^265160
 ;;^UTILITY(U,$J,358.3,18186,0)
 ;;=310.81^^98^1037^5
 ;;^UTILITY(U,$J,358.3,18186,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18186,1,2,0)
 ;;=2^310.81
 ;;^UTILITY(U,$J,358.3,18186,1,5,0)
 ;;=5^Pseudobulbar Affect
 ;;^UTILITY(U,$J,358.3,18186,2)
 ;;=^340506
 ;;^UTILITY(U,$J,358.3,18187,0)
 ;;=310.89^^98^1037^1
 ;;^UTILITY(U,$J,358.3,18187,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18187,1,2,0)
 ;;=2^310.89
 ;;^UTILITY(U,$J,358.3,18187,1,5,0)
 ;;=5^Brain Damage D/O,Oth Spec
 ;;^UTILITY(U,$J,358.3,18187,2)
 ;;=^268320
 ;;^UTILITY(U,$J,358.3,18188,0)
 ;;=V58.83^^99^1038^1
 ;;^UTILITY(U,$J,358.3,18188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18188,1,3,0)
 ;;=3^THERAPEUTIC DRUG MONITORING
 ;;^UTILITY(U,$J,358.3,18188,1,4,0)
 ;;=4^V58.83
 ;;^UTILITY(U,$J,358.3,18188,2)
 ;;=^322076
 ;;^UTILITY(U,$J,358.3,18189,0)
 ;;=99605^^100^1039^1^^^^1
 ;;^UTILITY(U,$J,358.3,18189,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18189,1,2,0)
 ;;=2^MTMS BY PHARM,INIT 15 MIN
 ;;^UTILITY(U,$J,358.3,18189,1,3,0)
 ;;=3^99605
 ;;^UTILITY(U,$J,358.3,18190,0)
 ;;=99607^^100^1039^2^^^^1
 ;;^UTILITY(U,$J,358.3,18190,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,18190,1,2,0)
 ;;=2^MTMS BY PHARM, EA ADDL 15 MIN
 ;;^UTILITY(U,$J,358.3,18190,1,3,0)
 ;;=3^99607
 ;;^UTILITY(U,$J,358.3,18191,0)
 ;;=99606^^100^1040^1^^^^1
 ;;^UTILITY(U,$J,358.3,18191,1,0)
 ;;=^358.31IA^3^2
